Search

everythinglearnresearchcommunity

for

Search:↓

Upadacitinib effectively treated severe atopic dermatitis, vitiligo, and alopecia areata in one patient.

Blocking CXCR4 may help treat hidradenitis suppurativa.

Brodalumab is more effective than ustekinumab in treating psoriasis.

High-dose corticosteroid treatment helped improve symptoms in a patient with Adult Onset Still Disease.

Black women with CCCA are more likely to have uterine fibroids.

A man's neck lump was a trichilemmal cyst, not cancer, and should be fully removed due to rare risk of becoming malignant.

ADM scaffolds help skin heal by promoting a healing-type immune response.

A specific group of immune and skin cells may cause chronic inflammation in atopic dermatitis.

Certain genetic variants reduce enzyme activity, contributing to non-classic congenital adrenal hyperplasia.

Mast cells may significantly contribute to central centrifugal cicatricial alopecia.

A man with Cronkhite-Canada syndrome improved significantly with immunosuppressive therapy.

Zinc deficiency in alcoholic cirrhosis patients causes skin issues, and zinc treatment improves symptoms.

The man has a genetic skin condition called pachyonychia congenita.

The CD44-CD49d complex boosts T cell activation and survival in autoimmune disease.

An elderly man had a rare, large skin cyst on his lower back, which was removed by surgery.

Adalimumab effectively stabilized severe folliculitis decalvans, preventing further hair loss and inflammation.

Upadacitinib improved multiple immune-related conditions in one patient.

CCCA involves immune response and metabolism issues, suggesting new treatment options.

AE can have varied symptoms and genetic causes, but zinc therapy helps.

Most adrenal cortex tumors are benign and non-secreting, but proper diagnosis and treatment are important due to the rare possibility of cancer.

Folliculitis decalvans is a rare skin disease causing hair loss and requires personalized treatment.

Amyloid deposits linked to a type of protein may cause a unique pattern of hair loss by disrupting hair growth cycles.

Tofacitinib and adalimumab are promising treatments for cicatricial alopecia with few side effects.

Azole antifungals can cause skin reactions like EAC, requiring careful management.

The treatment significantly improved lymphocytic cicatricial alopecia symptoms in most patients.

CYLD deficiency in skin tumors disrupts hair follicle cell processes and protein secretion.

Upadacitinib improves life quality for Alopecia Areata patients without worsening skin issues.